DAX ®12.661,94+0,06%TecDAX ®2.805,22+0,15%S&P FUTURE2.992,00-0,20%Nasdaq 100 Future7.938,25-0,18%
finanztreff.de

DGAP-PVR: Elanix Biotechnologies AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

| Quelle: Dow Jones Newsw... | Lesedauer etwa 4 min. | Text vorlesen Stop Pause Fortsetzen


DGAP Voting Rights Announcement: Elanix Biotechnologies AG
Elanix Biotechnologies AG: Release according to Article 40, Section 1 of the
WpHG [the German Securities Trading Act] with the objective of Europe-wide
distribution

2019-06-20 / 18:54
Dissemination of a Voting Rights Announcement transmitted by DGAP - a
service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

*Notification of Major Holdings*

*1. Details of issuer*
+++
|Name: |Elanix Biotechnologies AG |
+++
|Street: |c/o Frankfurt, Hanauer Landstrasse |
| |291 B |
+++
|Postal code: |60314 |
+++
|City: |Frankfurt am Main |
| |Germany |
+++
|Legal Entity Identifier |391200SYNFFL0NPAJK90 |
|(LEI): | |
+++
*2. Reason for notification*
+-++
| |Acquisition/disposal of shares with voting rights|
+-++
| |Acquisition/disposal of instruments |
+-++
| |Change of breakdown of voting rights |
+-++
|X|Other reason: |
| |Termination of the voting right agreement |
+-++
*3. Details of person subject to the notification obligation*
++
|Natural person (first name, surname): Lee Ann |
|Laurent-Applegate |
|Date of birth: 07 Aug 1962 |
++
|Legal entity: Elanix |
|City of registered office, country: Frankfurt am Main, |
|Germany |
++
*4. Names of shareholder(s)*
holding directly 3% or more voting rights, if different from 3.

++
||
++
*5. Date on which threshold was crossed or reached:*
++
|18 Dec 2018|
++
*6. Total positions*
++++++
| |% of voting| % of| Total of| Total number|
| | rights| voting| both in %| of voting|
| |attached to| rights| (7.a. +| rights|
| | shares| through| 7.b.)| pursuant to|
| | (total of|instrument| | Sec. 41 WpHG|
| | 7.a.)| s| | |
| | | (total of| | |
| | | 7.b.1 +| | |
| | | 7.b.2)| | |
++++++
|New | 12.85 %| 0 %| 12.85 %| 8.080.902|
++++++
|Previous | 19.35 %| 0 %| 19.35 %| /|
|notification | | | | |
++++++
*7. Details on total positions*
*a. Voting rights attached to shares (Sec. 33, 34 WpHG)*
++++++
|ISIN | Absolute | In % |
++++++
| | Direct| Indirect| Direct| Indirect|
| | (Sec. 33| (Sec. 34| (Sec. 33| (Sec. 34|
| | WpHG)| WpHG)| WpHG)| WpHG)|
++++++
|DE000A0WMJQ4| 1038609| 0| 12.85 %| 0 %|
++++++
|*Total* | 1038609 | 12.85 % |
++++++
*b.1. Instruments according to Sec. 38 (1) no. 1 WpHG*
++++++
|Type of |Expiration or |Exercise or | Voting| Voting|
|instrumen|maturity date |conversion | rights|rights in %|
|t | |period | absolute| |
++++++
| | | | | %|
++++++
| | |*Total* | | %|
++++++
*b.2. Instruments according to Sec. 38 (1) no. 2 WpHG*
+++++++
|Type of|Expiration |Exercise or|Cash or | Voting| Voting|
|instrum|or maturity |conversion |physical | rights|rights in|
|ent |date |period |settlemen| absolute| %|
| | | |t | | |
+++++++
| | | | | | %|
+++++++
| | | |*Total* | | %|
+++++++
*8. Information in relation to the person subject to the notification
obligation*

+-++
|X|Person subject to the notification obligation is not |
| |controlled nor does it control any other undertaking(s) that|
| |directly or indirectly hold(s) an interest in the |
| |(underlying) issuer (1.). |
+-++
| |Full chain of controlled undertakings starting with the |
| |ultimate controlling natural person or legal entity: |
+-++

+++++
|Name| % of voting| % of voting| Total of both (if at|
| | rights (if at| rights through| least 5% or more)|
| |least 3% or more)| instruments (if| |
| | | at least 5% or| |
| | | more)| |
+++++
| | | | |
+++++
*9. In case of proxy voting according to Sec. 34 para. 3 WpHG*
(only in case of attribution of voting rights in accordance with Sec. 34
para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general
meeting:

++++
| Proportion of voting| Proportion of|Total of both|
| rights| instruments| |
++++
| %| %| %|
++++
*10. Other explanatory remarks:*

++
||
++
Date

++
|20 Jun 2019|
++

2019-06-20 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de
Language: English
Company: Elanix Biotechnologies AG
c/o Frankfurt, Hanauer Landstrasse 291 B
60314 Frankfurt am Main
Germany
Internet: www.elanixbiotechnologies.com

End of News DGAP News Service

826591 2019-06-20



(END) Dow Jones Newswires

June 20, 2019 12:55 ET ( 16:55 GMT)
Werbung

Das könnte Sie auch interessieren

News-Suche

Suchbegriff:

Aktuelle Videos

zur Mediathek
Werbung

Werbung
Diese Seite empfehlenschliessen
Interessant, oder?
Teilen Sie diese Seite auf Facebook oder Twitter
Wenn Sie auf die Teilen-Buttons klicken und sich bei den Betreibern einloggen, werden Daten an den jeweiligen Betreiber übermittelt. Bitte beachten Sie die Datenschutzerklärung.
Aktuelle Umfrageschliessen
In Deutschland soll beim Aufbau des 5G-Netzes auch Huawei mitmischen dürfen. Finden Sie die Entscheidung der Bundesregierung richtig?
Jetzt abstimmen!
Alle Umfragen ansehen